Clinical Trials
Stanford Neurosurgery faculty are active in the conduct of clinical trials for a variety of brain diseases. Please check back frequently for updates.
If you or someone you know fit these criteria and are interested in learning more about this study, contact:
Stanford University Medical Center
Maria Coburn, Research Coordinator
300 Pasteur Drive, Room R200
Stanford , CA 94305-5327
650-723-5575
FIA Study
Have you or a family member been diagnosed with a brain aneurysm? Is there also a family history of brain aneurysms? We are conducting a genetic study entitled Familial Intracranial Aneurysm (FIA). The purpose of this research study is to identify possible genes that may increase the risk of stroke and particularly development of aneurysms in blood vessels of the brain.
Once enrolled into the study, we will draw about 4-5 teaspoons of blood, take 3 blood pressure readings, and you will answer some family history and medical history questions. After that, you will receive an annual follow-up questionnaire.
In order to qualify, you must be diagnosed with a brain aneurysm and have either one other sibling diagnosed with an aneurysm and/or two relatives who have been diagnosed.
Carotid Occlusion Surgery Study
If you have suffered a stroke within 120 days due to complete blockage of one of your internal carotid arteries (an artery that supplies blood to the brain), you may be eligible to participate in a Stanford University Medical Center research study. Stanford is conducting the Carotid Occlusion Surgery Study, a randomized, non-blinded study. The objective of this study is to test the hypothesis that a surgical procedure done to bypass the blocked internal carotid artery can reduce subsequent ischemic stroke by 40% at two years. You may be eligible for this study if you are between the ages of 18-85, have had symptoms within 4 months due to an internal carotid artery blockage, language comprehension is intact, and are competent to give informed consent. There will be approximately 4 clinic visits and 3 month follow-up visits for up to 2 years.
Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease
This study will evaluate the safety and efficacy of two different doses of Pasireotide in patients with de novo or recurrent/persistent Cushing's Disease.
Minimally Invasive Surgery Plus rt-PA for ICH Evacuation (MISTIE)
The purpose of this trial is to evaluate the safety of rt-PA, the study drug, when used in combination with minimal surgery (insertion of a catheter into the brain) in the removal of a blood clot from the brain. We propose to test if this intervention facilitates more rapid and complete recovery of function and decrease mortality in patients with an intra cerebral hemorrhage compared to conventional medical management without subjecting the patient to craniotomy. The specific objective of this trial is to test the safety of this intervention and assess its ability to remove blood clot from the brain tissue.
